mci 9038 has been researched along with Left Heart Hypoplasia Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boshkov, L; Giacomuzzi, C; Heller, E; Mejak, B; Shen, I; Ungerleider, R; You, X | 1 |
Boshkov, LK; Kirby, A; Shen, I; Ungerleider, RM | 1 |
1 review(s) available for mci 9038 and Left Heart Hypoplasia Syndrome
Article | Year |
---|---|
Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients.
Topics: Adolescent; Anticoagulants; Arginine; Autoantibodies; Cardiopulmonary Bypass; Child; Child, Preschool; Clinical Trials as Topic; Fatal Outcome; Female; Heart Defects, Congenital; Heparin; Hirudins; Hospitals, University; Humans; Hypoplastic Left Heart Syndrome; Infant; Infant, Newborn; Male; Multicenter Studies as Topic; Pipecolic Acids; Platelet Factor 4; Postoperative Complications; Postoperative Hemorrhage; Recombinant Proteins; Retrospective Studies; Sulfonamides; Thrombocytopenia; Thromboembolism; Treatment Outcome | 2006 |
1 other study(ies) available for mci 9038 and Left Heart Hypoplasia Syndrome
Article | Year |
---|---|
Argatroban usage for anticoagulation for ECMO on a post-cardiac patient with heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Blood Coagulation; Cardiopulmonary Bypass; Extracorporeal Membrane Oxygenation; Fatal Outcome; Heparin; Humans; Hypoplastic Left Heart Syndrome; Infant, Newborn; Pipecolic Acids; Postoperative Care; Sulfonamides; Thrombocytopenia | 2004 |